Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs.
作者信息
Barnes J N, Williams A J, Tomson M J, Toseland P A, Goodwin F J
出版信息
Br Med J (Clin Res Ed). 1985 Mar 9;290(6470):740-2. doi: 10.1136/bmj.290.6470.740.
Abstract
The pharmacokinetics of a single oral dose of dihydrocodeine were studied in nine patients with chronic renal failure treated by haemodialysis and nine subjects with normal renal function. In the patients the mean peak plasma dihydrocodeine concentration occurred later and the area under the curve was greater than in the normal subjects. Furthermore, the drug was still detectable after 24 hours in all the patients but only three of the normal subjects. These data, together with those obtained from previously published clinical case reports, contradict the traditional view that the body's ability to cope with opioid drugs is not altered in renal failure.
摘要
相似文献
1
Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs.
Br Med J (Clin Res Ed). 1985 Mar 9;290(6470):740-2. doi: 10.1136/bmj.290.6470.740.
2
The effect of ageing on the pharmacokinetics of dihydrocodeine.
Eur J Clin Pharmacol. 1989;37(4):375-9. doi: 10.1007/BF00558503.
3
Opioid drugs and renal failure.
Lancet. 1984 Sep 29;2(8405):748. doi: 10.1016/s0140-6736(84)92651-5.
4
Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
Kidney Int. 2000 Mar;57(3):1164-8. doi: 10.1046/j.1523-1755.2000.00943.x.
5
Dihydrocodeine in renal failure.
Br Med J (Clin Res Ed). 1985 Apr 27;290(6477):1287. doi: 10.1136/bmj.290.6477.1287.
6
Metabolism and pharmacokinetics of dihydrocodeine in dog.
Xenobiotica. 1994 Jul;24(7):591-601. doi: 10.3109/00498259409043262.
7
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites.
Clin Pharmacokinet. 2007;46(3):235-46. doi: 10.2165/00003088-200746030-00004.
8
Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxication.
Forensic Sci Int. 1998 Jul 20;95(2):99-107. doi: 10.1016/s0379-0738(98)00091-7.
9
Dihydrocodeine: a new opioid substrate for the polymorphic CYP2D6 in humans.
Clin Pharmacol Ther. 1995 Oct;58(4):374-82. doi: 10.1016/0009-9236(95)90049-7.
10
Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites.
Eur J Clin Pharmacol. 1983;25(3):419-24. doi: 10.1007/BF01037958.
引用本文的文献
1
Population pharmacokinetics of telapristone (CDB-4124) and its active monodemethylated metabolite CDB-4453, with a mixture model for total clearance.
AAPS J. 2011 Dec;13(4):665-73. doi: 10.1208/s12248-011-9304-7. Epub 2011 Oct 25.
2
An analysis of discharge drug prescribing amongst elderly patients with renal impairment.
Postgrad Med J. 1998 Jul;74(873):420-2. doi: 10.1136/pgmj.74.873.420.
3
Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.
Drug Saf. 1998 Jun;18(6):457-72. doi: 10.2165/00002018-199818060-00006.
4
Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.
Drug Saf. 1997 Mar;16(3):205-31. doi: 10.2165/00002018-199716030-00005.
5
Principles of drug administration in renal insufficiency.
Clin Pharmacokinet. 1997 Jan;32(1):30-57. doi: 10.2165/00003088-199732010-00002.
6
Pharmacokinetics of opioids in renal dysfunction.
Clin Pharmacokinet. 1996 Dec;31(6):410-22. doi: 10.2165/00003088-199631060-00002.
7
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.
Clin Pharmacokinet. 1988 Jun;14(6):347-73. doi: 10.2165/00003088-198814060-00003.
8
Morphine intoxication in renal failure; the role of morphine-6-glucuronide.
Br Med J (Clin Res Ed). 1986 Oct 25;293(6554):1101. doi: 10.1136/bmj.293.6554.1101.
9
Guide to drug dosage in renal failure.
Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005.
10
The effect of ageing on the pharmacokinetics of dihydrocodeine.
Eur J Clin Pharmacol. 1989;37(4):375-9. doi: 10.1007/BF00558503.
本文引用的文献
1
The metabolic fate of codeine in man.
J Pharmacol Exp Ther. 1955 Jul;114(3):251-62.
2
Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney.
J Pharmacol Exp Ther. 1982 Dec;223(3):811-5.
3
Metabolism of narcotics.
Br Med J (Clin Res Ed). 1984 Jan 21;288(6412):237. doi: 10.1136/bmj.288.6412.237.
4
Dihydrocodeine narcosis in renal failure.
Br Med J (Clin Res Ed). 1983 Feb 5;286(6363):438-9. doi: 10.1136/bmj.286.6363.438-a.
5
Morphine kinetics during and after renal transplantation.
Clin Pharmacol Ther. 1984 May;35(5):641-5. doi: 10.1038/clpt.1984.88.
6
Drug prescribing in renal failure: dosing guidelines for adults.
Am J Kidney Dis. 1983 Nov;3(3):155-93. doi: 10.1016/s0272-6386(83)80060-2.
7
Gastric acid secretion in chronic renal failure.
Br Med J. 1972 Oct 7;4(5831):22-3. doi: 10.1136/bmj.4.5831.22.
8
Stop-flow analysis of the renal excretion of tritium-labeled dihydromorphine.
J Pharmacol Exp Ther. 1965 Nov;150(2):259-69.
9
Narcotic analgesics in anuric patients.
Anesthesiology. 1975 Jun;42(6):745-7. doi: 10.1097/00000542-197506000-00021.
10
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
Clin Pharmacol Ther. 1975 Jun;17(6):677-84. doi: 10.1002/cpt1975176677.
Zotero 插件